Literature DB >> 21682720

Activation of natural killer cells by hepatitis C virus particles in vitro.

M M S Farag1, K Weigand, J Encke, F Momburg.   

Abstract

Little is known about the ability of hepatitis C virus (HCV) to alter early innate immune responses in infected patients. Previous studies have shown that natural killer (NK) cells are functionally impaired after interaction of recombinant HCV glycoprotein E2 with the co-stimulatory CD81 molecule in vitro; however, the functional consequences of a prolonged contact of NK cells with HCV particles have remained unclear. We have examined the phenotypes of purified, interleukin-2-activated NK cells from healthy donors and HCV genotype 1b patients after culture for 5 days with HCV pseudoparticles (HCVpp) and serum samples containing HCV genotype 1b. NK cells from healthy donors and chronic HCV patients were found to up-regulate receptors associated with activation (NKp46, NKp44, NKp30, NKG2D), while NK receptors from the killer cell immunoglobulin-like receptor family (KIR/CD158), predominantly having an inhibitory function, were significantly down-modulated after culture in the presence of HCV particles compared with control cultures of NK cells. HCV-infected sera and HCVpp elicited significantly higher secretion of the NK effector lymphokines interferon-γ and tumour necrosis factor-α. Furthermore, HCV stimulated the cytotoxic potential of NK cells from normal donors and patients. The enhanced activation of NK cells after prolonged culture with HCVpp or HCV-containing sera for 5 days suggests that these innate effector cells may play an important role in viral control during early phases of HCV infection.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21682720      PMCID: PMC3170984          DOI: 10.1111/j.1365-2249.2011.04431.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.

Authors:  Masahisa Jinushi; Tetsuo Takehara; Tomohide Tatsumi; Tatsuya Kanto; Takuya Miyagi; Takahiro Suzuki; Yoshiyuki Kanazawa; Naoki Hiramatsu; Norio Hayashi
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

Review 2.  Altered innate immunity in chronic hepatitis C infection: cause or effect?

Authors:  Gyongyi Szabo; Serena Chang; Angela Dolganiuc
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

3.  Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients.

Authors:  Andrea De Maria; Manuela Fogli; Stefania Mazza; Monica Basso; Antonio Picciotto; Paola Costa; Sonia Congia; Maria Cristina Mingari; Lorenzo Moretta
Journal:  Eur J Immunol       Date:  2007-02       Impact factor: 5.532

4.  Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C.

Authors:  U Düesberg; A M Schneiders; D Flieger; G Inchauspé; T Sauerbruch; U Spengler
Journal:  J Hepatol       Date:  2001-11       Impact factor: 25.083

5.  Cytokine-activated natural killer cells exert direct killing of hepatoma cells harboring hepatitis C virus replicons.

Authors:  Jonathan Larkin; Anne Bost; John I Glass; Seng-Lai Tan
Journal:  J Interferon Cytokine Res       Date:  2006-12       Impact factor: 2.607

6.  Activation of natural killer cells during acute infection with hepatitis C virus.

Authors:  Barbara Amadei; Simona Urbani; Angelica Cazaly; Paola Fisicaro; Alessandro Zerbini; Parvin Ahmed; Gabriele Missale; Carlo Ferrari; Salim I Khakoo
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

7.  Increased frequency of CD56Bright NK-cells, CD3-CD16+CD56- NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25High T-cells control potentially viremia in blood donors with HCV.

Authors:  Maria Alice Sant'anna Zarife; Eliana Almeida Gomes Reis; Theomira Mauadie Azevedo Carmo; Gisele Barreto Lopes; Emilia Carolina Malafaia Brandão; Helder Reis Silva; Nelma Santana; Olindo Assis Martins-Filho; Mitermayer Galvão Reis
Journal:  J Med Virol       Date:  2009-01       Impact factor: 2.327

8.  Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.

Authors:  Barbara Oliviero; Stefania Varchetta; Enrica Paudice; Giuseppe Michelone; Marco Zaramella; Domenico Mavilio; Francesca De Filippi; Savino Bruno; Mario U Mondelli
Journal:  Gastroenterology       Date:  2009-05-24       Impact factor: 22.682

Review 9.  Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence.

Authors:  Barbara Rehermann
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

10.  Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.

Authors:  Stefania Crotta; Annalisa Stilla; Andreas Wack; Annalisa D'Andrea; Sandra Nuti; Ugo D'Oro; Marta Mosca; Franco Filliponi; R Maurizia Brunetto; Ferruccio Bonino; Sergio Abrignani; Nicholas M Valiante
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

View more
  6 in total

1.  NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by Cytokines.

Authors:  Alena C Jaime-Ramirez; Elizabeth McMichael; SriVidya Kondadasula; Cassandra C Skinner; Bethany L Mundy-Bosse; Eric Luedke; Natalie B Jones; Aruna Mani; Julie Roda; Volodymyr Karpa; Hong Li; Jilong Li; Saranya Elavazhagan; Krista M La Perle; Alessandra C Schmitt; Yanhui Lu; Xiaoli Zhang; Xueliang Pan; Hsaioyin Mao; Melanie Davis; David Jarjoura; Jonathan P Butchar; Ming Poi; Mitch Phelps; Susheela Tridandapani; John C Byrd; Michael A Caligiuri; Robert J Lee; William E Carson
Journal:  Cancer Immunol Res       Date:  2016-02-10       Impact factor: 11.151

Review 2.  Virus-mediated inhibition of natural cytotoxicity receptor recognition.

Authors:  Einat Seidel; Ariella Glasner; Ofer Mandelboim
Journal:  Cell Mol Life Sci       Date:  2012-05-01       Impact factor: 9.207

3.  Interferon-α improves phosphoantigen-induced Vγ9Vδ2 T-cells interferon-γ production during chronic HCV infection.

Authors:  Eleonora Cimini; Cécile Bonnafous; Veronica Bordoni; Eleonora Lalle; Helene Sicard; Alessandra Sacchi; Giulia Berno; Cristiana Gioia; Gianpiero D'Offizi; Ubaldo Visco Comandini; Chrysoula Vlassi; Maria Rosaria Capobianchi; Federico Martini; Chiara Agrati
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

Review 4.  CD81 and hepatitis C virus (HCV) infection.

Authors:  Lucie Fénéant; Shoshana Levy; Laurence Cocquerel
Journal:  Viruses       Date:  2014-02-06       Impact factor: 5.048

5.  Chronic HCV infection affects the NK cell phenotype in the blood more than in the liver.

Authors:  Cormac Cosgrove; Christoph T Berger; Daniela C Kroy; Patrick C Cheney; Musie Ghebremichael; Jasneet Aneja; Michelle Tomlinson; Arthur Y Kim; Georg M Lauer; Galit Alter
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

Review 6.  The Evolutionary Arms Race between Virus and NK Cells: Diversity Enables Population-Level Virus Control.

Authors:  Sarah K A Savoy; Jeanette E Boudreau
Journal:  Viruses       Date:  2019-10-17       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.